WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
More News: COVID-19 | Health | Hydroxychloroquine | Infectious Diseases | International Medicine & Public Health | Malaria | WHO